Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir in Ageing Type 2 Diabetes
NCT00506662Phase 4Terminated
- Sponsor
- Novo Nordisk
- Start
- Jul 2007
- Primary completion
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of insulin detemir in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Change in Glycosylated Haemoglobin (HbA1c) at 7 months. Started Jul 2007; status: terminated.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00506662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506662.